Investment Trusts

Polar Capital Global Healthcare Trust

PCGH:LSE

Polar Capital Global Healthcare Trust

  • Price (GBX)363.00
  • Today's Change0.00 / 0.00%
  • Shares traded246.28k
  • 1 Year change19.80%
  • Beta0.5984
Data delayed at least 20 minutes, as of Nov 21 2024 16:39 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Polar Capital Global Healthcare Trust plc is a United Kingdom-based investment trust company. The Company’s investment objective is to generate capital growth by investing in a global portfolio of healthcare stocks. The Company seeks to achieve its objective by investing in a diversified global portfolio consisting primarily of listed equities. The portfolio is diversified by factors such as geography, industry sub-sector and investment size. Its portfolio of investment across various sectors includes pharmaceuticals, biotechnology, healthcare equipment, managed healthcare, healthcare supplies, life sciences tools and services, healthcare facilities, metal, glass and plastic containers, healthcare technology, healthcare distributors, and healthcare services. The Company’s investment manager and alternative investment fund manager (AIFM) is Polar Capital LLP.

  • Revenue in GBP (TTM)85.55m
  • Net income in GBP78.00m
  • Incorporated2010
  • Employees0.00
More ▼

Profile

Management group(s)Polar Capital LLP
AIC sectorBiotechnology & Healthcare
ISINGB00B6832P16
Launch date15 Jun 2010
Share typeOrdinary Share
StructureInvestment Trust
Base currencyGBP

Objective

The Company’s investment objective is to generate capital growth by investing in a global portfolio of healthcare stocks.The Company seeks to achieve this objective by investing in a diversified global portfolio consisting primarily of listed equities issued by healthcare companies involved in pharmaceuticals, medical services, medical devices and biotechnology. The portfolio is expected to be diversified by factors such as geography, industry sub-sector and investment size.

Managed by

David Pinniger, James Douglas, Deane Donnigan, Gareth Powell

Management & contract fees

Management fee is 0.75% p.a. of the lower of the Market Capitalisation and NAV. Performance fee is equal to 10% of the excess total return over benchmark Index plus 1.5% p.a. compounded annually. Agreement terminable not less than 12 months written notice.

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Octopus Apollo VCT PLC5.51m-4.95m416.31m0.00416.31m0.00
Jpmorgan Uk Small Cap Growth & IncomePLC104.52m99.70m417.79m0.00417.79m0.00
NextEnergy Solar Fund Ltd8.82m-8.36m418.96m0.00418.96m0.00
Pantheon Infrastructure PLC66.24m77.42m422.70m0.00422.70m0.00
Impax Asset Management Group Plc176.56m40.67m424.31m290.00424.31m290.00
Tatton Asset Management PLC40.96m15.34m424.79m103.00424.79m103.00
North American Income Trust PLC61.93m54.54m425.66m0.00425.66m0.00
Abrdn Asia Focus PLC55.49m37.33m430.22m0.00430.22m0.00
Pollen Street Group Ltd108.82m46.52m431.70m84.00431.70m84.00
Polar Capital Global Healthcare Trst PLC85.55m78.00m441.32m0.00441.32m0.00
Jupiter Fund Management PLC398.00m-8.90m441.43m527.00441.43m527.00
Schroder Asian Totl Retrn Invstmt Co PLC76.65m68.75m443.15m0.00443.15m0.00
Pacific Assets Trust plc60.61m42.83m450.45m0.00450.45m0.00
Georgia Capital PLC52.50m50.59m454.38m47.00454.38m47.00
Foresight Solar Fund Ltd14.40m6.40m454.52m0.00454.52m0.00
Ashoka India Equity Investment Trust PLC113.79m96.65m466.67m0.00466.67m0.00
Data as of Nov 21 2024. Currency figures normalised to Polar Capital Global Healthcare Trust's reporting currency: UK Pound GBX
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.